Anbio Biotechnology
Last updated September 27, 2026
Organization details
- Legal name
- Anbio Biotechnology
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2835 — In Vitro & In Vivo Diagnostic Substances
- Jurisdiction of incorporation
- Cayman Islands
- Headquarters city
- Frankfurt AM Main
- Headquarters country
- Germany
- Fiscal year end
- December
- Ticker symbol
- NNNN
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001982708
Board of directors
-
Cany Xu · DirectorSince 2026
-
David H. Hsu · DirectorSince 2026
-
Michael W.c Zhang · DirectorSince 2026
-
Nancy Hartzler · DirectorSince 2026
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Anbio Biotechnology
How many directors are on Anbio Biotechnology's board?
Anbio Biotechnology's board has 4 directors: Cany Xu, David H. Hsu, Michael W.c Zhang and Nancy Hartzler.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="anbio-biotechnology"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.